You are here

Eli Lilly

Teva slumps after Express Scripts funds migraine rivals in US

Teva slumps after Express Scripts funds migraine rivals in US

Pharmaforum

Teva Pharmaceutical

Express Scripts

Flag link:

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Biopharma Dive

Flag link:

Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug

Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug

Yahoo/Reuters

Express Scripts

Teva Pharmaceutical

Flag link:

Trump wants drug commercials to include prices. These five companies have the most at stake

Trump wants drug commercials to include prices. These five companies have the most at stake

Stat

Flag link:

New York biotech snaps up Eli Lilly neuro veteran as CSO

New York biotech snaps up Eli Lilly neuro veteran as CSO

Fierce Biotech

Redpin Therapeutics

Flag link:

Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report

Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report

Fierce Pharma

Flag link:

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

CP Wire

Boehringer Ingelheim

type 2 diabetes

Flag link:

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

Boehringer Ingelheim

Flag link:

4 Reasons to Be Wary of This Animal Health IPO

4 Reasons to Be Wary of This Animal Health IPO

Motley Fool

Flag link:

Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts

Lilly makes waves with next-generation diabetes drug, but GLP-1 rivals needn't panic: analysts

Fierce Pharma

Flag link:

Lilly’s breast cancer drug Verzenio approved in EU

Lilly’s breast cancer drug Verzenio approved in EU

Pharmaforum

Flag link:

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?

Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is that enough?

Fierce Pharma

Boehringer Ingelheim

Flag link:

Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results

Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results

Endpoints

Flag link:

Eli Lilly's diabetes treatment meets main goal in two late-stage studies

Eli Lilly's diabetes treatment meets main goal in two late-stage studies

Reuters

Ultra Rapid Lispro

type 1 diabetes

type 2 diabetes

Flag link:

Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags

Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags

Marketwatch

Teva Pharmaceutical

Flag link:

Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster

Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster

Fierce Pharma

Teva Pharmaceutical

erectile dysfunction

Flag link:

Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP

Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP

Fierce Pharma

Flag link:

Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront

Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront

BioSpace

type 2 diabetes

Flag link:

Elanco’s $1.7 billion IPO looks too pricey, and here’s why

Elanco’s $1.7 billion IPO looks too pricey, and here’s why

Marketwatch

Flag link:

Eli Lilly got Indianapolis tax break despite pending appeals

Eli Lilly got Indianapolis tax break despite pending appeals

AP

Flag link:

Pages